epipen
-
Do Mylan’s EpiPen Contracts With US Schools Break Antitrust Laws?
Mylan Pharmaceuticals, the makers of the EpiPen, spent the past decade making sure that its life-saving allergy product was in as many US public schools as possible. But the company has come under fire in recent weeks for raising the price of the drug from roughly $US57 ($75) in 2007 to about $US600 ($791) today…
-
How US Congress, The FDA And Sarah Jessica Parker Helped EpiPen Become A $1.3 Billion Business
EpiPen, the life-saving allergy product, is now a $US1 billion ($1.3 billion) a year business for Mylan, a drug company that’s currently enduring a wave of bad publicity over the extraordinary surge in US EpiPen pricing. In 2007, an EpiPen in the US cost about $US57 ($75). Today that price has skyrocketed to over $US600…